Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Boston Scientific (BSX) Any Comments??? -- Ignore unavailable to you. Want to Upgrade?

To: yard_man who wrote (398)	7/10/1998 3:29:00 PM
From: yard_man	Respond to of 798

CHICAGO, July 10 (Reuters) - Another quarter of modest profit growth is expected to be reported by U.S. medical device makers, with the strong dollared to hold open narrow blood vessels in the heart. Arterial is expected by analysts to post earnings 775 percent above a year ago, while Guidant earnings are projected by analysts to more than double. Hopping aboard the stent wave this quarter will be Boston Scientific Corp. (BSX - news), expected soon to launch its first stent. But Boston's stentless second-quarter results will be down from a year ago, analysts estimated. Growth estimates for 10 other large-cap firms fall into a narrower range averaging about 10 percent. ''These growth rates are in line with the moderating trends the industry has been reporting for several quarters,'' said BT Alex. Brown industry analyst Jonathan Osgood. Through the first half, the medical device sector continued to underperform broader market averages, according to Goldman Sachs. The investment firm's cap-weighted medical device industry index was up 14.4 percent over the first six months of 1998, versus a 16.8-percent gain in the S&P 500 index. biz.yahoo.com

To: yard_man who wrote (398)	7/14/1998 10:45:00 AM
From: yard_man	Read Replies (2) \| Respond to of 798

Tuesday July 14, 10:15 am Eastern Time RESEARCH ALERT-Vector cuts 3 medical device stocks DEERFIELD, Ill., July 14 (Reuters) - Vector Securities said it downgraded the following medical device stocks: --Medtronic Inc. to attractive from buy. --Boston Scientific Corp. to attractive from buy. --Arrow International Inc. to neutral from attractive. The firm said it was maintaining buy ratings on Arterial Vascular Engineering Inc. (AVEI - news), Perclose Inc. (PERC - news) and Cardiac Pathways Corp. (CPWY - news), as well as a neutral rating on St. Jude Medical Inc. (STJ - news). The adjustments, largely based on valuations, were made by Vector analysts Carl Belczynski and Sandra Hollenhorst.